Authors: Crowne, EC Samra, JS Cheetham, T Acerini, CL Watts, A Holly, JMP Dunger, DB

Citation: Ec. Crowne et al., The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus, J CLIN END, 86(8), 2001, pp. 3686-3691

Authors: Acerini, CL Dunger, DB

Citation: Cl. Acerini et Db. Dunger, Insulin-like growth factor-I for the treatment of type 1 diabetes, DIABET OB M, 2(6), 2000, pp. 335-343

Authors: Acerini, CL Cheetham, TD Edge, JA Dunger, DB

Citation: Cl. Acerini et al., Both insulin sensitivity and insulin clearance in children and young adults with Type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age, DIABETOLOG, 43(1), 2000, pp. 61-68

Authors: Acerini, CL Hughes, IA

Citation: Cl. Acerini et Ia. Hughes, 21-Hydroxylase deficiency defects and their phenotype, ENDOCR DEV, 2, 2000, pp. 93-111

Authors: Acerini, CL Harris, DA Matyka, KA Watts, AP Umpleby, AM Russell-Jones, DL Dunger, DB

Citation: Cl. Acerini et al., Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus, METABOLISM, 47(12), 1998, pp. 1481-1489